首頁 > 市場調查報告書 > 製藥

醫藥品原料藥

市場調查報告書

商品編碼

1572711

全球活性藥物成分 (API) 市場

Active Pharmaceutical Ingredients: Global Markets

出版日期: 2024年10月17日 | 出版商:

BCC Research | 英文 119 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球活性藥物成分（API）市場規模預計將從2023年的2,478億美元成長到2029年的3,479億美元，預測期內複合年成長率為5.9%。

在製造業中，化學合成產業預計將從2023年的1,813億美元成長到2029年的2,461億美元，複合年成長率為5.4%。生技產業預計將從 2023 年的 665 億美元成長到 2029 年的 1,017 億美元，複合年成長率為 7.4%。

本報告調查了全球活性藥物成分（API）市場，並提供了市場概況、市場影響因素和市場機會分析、法律制度、新興技術和技術發展趨勢、市場規模趨勢和預測以及各種詳細總結。按細分和地區分析、競爭狀況、主要企業概況等

市場動態簡介
市場促進因素
醫藥需求富彈性
學名藥的採用增加
轉向更複雜的化學品
生物製藥市場的成長
API 製造的進步
政府支持
市場限制因素
嚴格的法規和合規要求
非專利藥產業的定價壓力
缺乏熟練的專業人員
市場趨勢
對複雜 API 的需求增加
區域多角化和供應鏈彈性
連續流製造
一次性技術的擴展
擴大 API 製造的永續性實踐
外包和 CDMO夥伴關係關係的增加

第4章新興科技與發展

用於複雜合成 API 生產的生物催化劑
人工智慧和機器學習整合
軟性製造

第5章市場區隔分析

細分細分
API 市集：按製造商類型
內部和契約製造市場
商業市場
API 市場：依製造方法分類
化學合成
生物技術
API 市集：按分子類型
小分子原料藥
高分子
地域分佈
API 市集：按地區
北美洲
歐洲
亞太地區
其他領域

第6章競爭訊息

供應商情況
內部API製造商
契約製造製造商
商業原料藥製造商
一般API：市場狀況
創新API：市場情勢
波特五力分析

第7章附錄

調查方法
來源
簡稱
公司簡介
AUROBINDO PHARMA
DIVI'S LABORATORIES LTD.
EUROAPI
EVONIK INDUSTRIES AG
LONZA
PFIZER INC.
SIEGFRIED HOLDING AG
TEVA PHARMACEUTICAL INDUSTRIES LTD.
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC

簡介目錄圖表

Product Code: PHM200C

The global market for active pharmaceutical ingredients (APIs) is estimated to increase from $247.8 billion in 2023 to reach $347.9 billion by 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.

The chemical synthesis market for APIs is estimated to increase from $181.3 billion in 2023 to reach $246.1 billion by 2029, at a CAGR of 5.4% from 2024 through 2029.

The biotech market for APIs is estimated to increase from $66.5 billion in 2023 to reach $101.7 billion by 2029, at a CAGR of 7.4% from 2024 through 2029.

Report Scope

This goal of this report is to impart in-depth knowledge of the global market for active pharmaceutical ingredients (APIs), in terms of both qualitative and quantitative data, to help readers assess the market landscape, develop business/growth strategies, and analyze their market position. BCC Research estimates market size for 2023 (the base year) and forecasts values for 2024 by the end of 2029. It is important to note that market size reflects the demand for APIs within a region or country rather than the API industry itself.

In this report, the API market is analyzed by manufacturer type, production method, molecule type, region and country. Industry growth trends, drivers, restraints and opportunities in the API market are also discussed in detail. The scope of the study is global.

Report Includes

64 data tables and 38 additional tables
An analysis of the global markets for active pharmaceutical ingredients (APIs)
Analyses of global market trends, with market revenue data from 2022 to 2023, estimates for 2024, forecast for 2025, and projected CAGRs through 2029
Estimates of the size and revenue prospects of the global market, along with a market share analysis by origin, drug molecular entity type, manufacturer type, end use and region
Facts and figures pertaining to the market dynamics, technical advances, API sources, production methods, route of synthesis, regulations, and the impact of macroeconomic variables
A Porter's Five Forces model, and global supply chain and PESTLE analyses
Patent activity featuring issues like patent expiry and its impact on the pharmaceutical market, and details of changes in pharmaceutical drug development
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity and a venture funding outlook
Company profiles of major players within the industry, including Pfizer Inc., Thermo Fisher Scientific Inc., EuroAPI, Lonza, Siegfried Holding AG, and Divi's Laboratories Ltd.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

APIs Defined
Global API Supply Chain
API Production Methods
API Production: Route of Synthesis
Production Methods

Chapter 3 Market Dynamics

Market Dynamics Snapshot
Market Drivers
Resilient Pharmaceutical Demand
Increase in Adoption of Generics
Shift to More Complex Chemical Entities
Growth in the Biologics Market
Advances in API Manufacturing
Government Support
Market Restraints
Strict Regulations and Compliance Requirements
Pricing Pressure in the Generic API Industry
Shortage of Skilled Professionals
Market Trends
Increasing Demand for Complex APIs
Regional Diversification and Supply Chain Resilience
Continuous Flow Manufacturing
Expansion of Single-Use Technologies
Growing Sustainability Practices in API Manufacturing
Increased Outsourcing and CDMO Partnerships

Chapter 4 Emerging Technologies and Developments

Biocatalysis for Complex Synthetic API Manufacturing
Integration of AI and ML
Flexible Manufacturing

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
API Market, by Manufacturer Type
Captive and Contract Manufacturing Market
Merchant Market
API Market, by Production Method
Chemical Synthesis
Biotech
API Market, by Molecule Type
Small-Molecule APIs
Large Molecule
Geographic Breakdown
API Market, by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Supplier Landscape
Captive Manufacturers
Contract Manufacturers
Merchant Manufacturers
Generic API Market Landscape
Innovative API Market Landscape
Porter's Five Forces Analysis

Chapter 7 Appendix

Methodology
Sources
Abbreviations
Company Profiles
AUROBINDO PHARMA
DIVI'S LABORATORIES LTD.
EUROAPI
EVONIK INDUSTRIES AG
LONZA
PFIZER INC.
SIEGFRIED HOLDING AG
TEVA PHARMACEUTICAL INDUSTRIES LTD.
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC

簡介目錄圖表

List of Tables

Summary Table : Global Market for APIs, by Production Method, Through 2029
Table 1 : Regulatory Requirements of GMP and Supply Chain Integrity for APIs
Table 2 : Recent Spin-offs and Separations of API Companies
Table 3 : Biocatalysis in API Production: Benefits and Challenges
Table 4 : Global Market for APIs, by Manufacturer Type, Through 2029
Table 5 : Global Market for Captive and Contract Manufacturer APIs, by Region, Through 2029
Table 6 : Global Market for Merchant APIs, by Region, Through 2029
Table 7 : Global Market for APIs, by Production Method, Through 2029
Table 8 : Biotech Production Methods: Attributes and Applications
Table 9 : Global Market for Biotech APIs, by Production Method, Through 2029
Table 10 : Global Market for APIs, by Molecule Type, Through 2029
Table 11 : Characteristics of Small Molecules
Table 12 : Global Market for Small-Molecule APIs, by Type, Through 2029
Table 13 : Global Market for Small-Molecule APIs, by Manufacturer Type, Through 2029
Table 14 : Characteristics of Large Molecules/Biologics
Table 15 : Global Market for Large-Molecule APIs, by Type, Through 2029
Table 16 : Global Market for Large-Molecule APIs, by Manufacturer Type, Through 2029
Table 17 : Global Market for APIs, by Region, Through 2029
Table 18 : North American Market for APIs, by Manufacturer Type, Through 2029
Table 19 : North American Market for APIs, by Production Method, Through 2029
Table 20 : North American Market for APIs, by Molecule Type, Through 2029
Table 21 : North American Market for APIs, by Country, Through 2029
Table 22 : U.S. Market for APIs, by Production Method, Through 2029
Table 23 : U.S. Market for APIs, by Molecule Type, Through 2029
Table 24 : Canadian Market for APIs, by Production Method, Through 2029
Table 25 : Canadian Market for APIs, by Molecule Type, Through 2029
Table 26 : Mexican Market for APIs, by Production Method, Through 2029
Table 27 : Mexican Market for APIs, by Molecule Type, Through 2029
Table 28 : European Market for APIs, by Manufacturer Type, Through 2029
Table 29 : European Market for APIs, by Production Method, Through 2029
Table 30 : European Market for APIs, by Molecule Type, Through 2029
Table 31 : European Market for APIs, by Country, Through 2029
Table 32 : German Market for APIs, by Production Method, Through 2029
Table 33 : German Market for APIs, by Molecule Type, Through 2029
Table 34 : French Market for APIs, by Production Method, Through 2029
Table 35 : French Market for APIs, by Molecule Type, Through 2029
Table 36 : U.K. Market for APIs, by Production Method, Through 2029
Table 37 : U.K. Market for APIs, by Molecule Type, Through 2029
Table 38 : Italian Market for APIs, by Production Method, Through 2029
Table 39 : Italian Market for APIs, by Molecule Type, Through 2029
Table 40 : Spanish Market for APIs, by Production Method, Through 2029
Table 41 : Spanish Market for APIs, by Molecule Type, Through 2029
Table 42 : Rest of European Market for APIs, by Production Method, Through 2029
Table 43 : Rest of European Market for APIs, by Molecule Type, Through 2029
Table 44 : Asia-Pacific Market for APIs, by Manufacturer Type, Through 2029
Table 45 : Asia-Pacific Market for APIs, by Production Method, Through 2029
Table 46 : Asia-Pacific Market for APIs, by Molecule Type, Through 2029
Table 47 : Asia-Pacific Market for APIs, by Country, Through 2029
Table 48 : Chinese Market for APIs, by Production Method, Through 2029
Table 49 : Chinese Market for APIs, by Molecule Type, Through 2029
Table 50 : Japanese Market for APIs, by Production Method, Through 2029
Table 51 : Japanese Market for APIs, by Molecule Type, Through 2029
Table 52 : Indian Market for APIs, by Production Method, Through 2029
Table 53 : Indian Market for APIs, by Molecule Type, Through 2029
Table 54 : Rest of APAC Market for APIs, by Production Method, Through 2029
Table 55 : Rest of APAC Market for APIs, by Molecule Type, Through 2029
Table 56 : RoW Market for APIs, by Manufacturer Type, Through 2029
Table 57 : RoW Market for APIs, by Production Method, Through 2029
Table 58 : RoW Market for APIs, by Molecule Type, Through 2029
Table 59 : RoW Market for APIs, by Country, Through 2029
Table 60 : Key API Manufacturers
Table 61 : Report Sources
Table 62 : Abbreviations Used in this Report
Table 63 : Aurobindo Pharma: Company Snapshot
Table 64 : Aurobindo Pharma: Financial Performance, FY 2023 and 2024
Table 65 : Aurobindo Pharma: Product Portfolio
Table 66 : Aurobindo Pharma: News/Key Developments, 2022-2024
Table 67 : Divi's Laboratories Ltd.: Company Snapshot
Table 68 : Divi's Laboratories Ltd.: Financial Performance, FY 2023 and 2024
Table 69 : Divi's Laboratories Ltd.: Product Portfolio
Table 70 : EUROAPI: Company Snapshot
Table 71 : EUROAPI: Financial Performance, FY 2022 and 2023
Table 72 : EUROAPI: Product Portfolio
Table 73 : EUROAPI: News/Key Developments, 2022-2024
Table 74 : Evonik Industries AG: Company Snapshot
Table 75 : Evonik Industries AG: Financial Performance, FY 2022 and 2023
Table 76 : Evonik Industries AG: Product Portfolio
Table 77 : Evonik Industries AG: News/Key Developments, 2022-2024
Table 78 : Lonza: Company Snapshot
Table 79 : Lonza: Financial Performance, FY 2022 and 2023
Table 80 : Lonza: Product Portfolio
Table 81 : Lonza: News/Key Developments, 2022-2024
Table 82 : Pfizer Inc.: Company Snapshot
Table 83 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 84 : Pfizer Inc: Product Portfolio
Table 85 : Pfizer Inc.: News/Key Developments, 2022-2024
Table 86 : Siegfried Holding AG: Company Snapshot
Table 87 : Siegfried Holding AG: Financial Performance, FY 2022 and 2023
Table 88 : Siegfried Holding AG: Product Portfolio
Table 89 : Siegfried Holding AG: News/Key Developments, 2022-2024
Table 90 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 91 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
Table 92 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 93 : Teva Pharmaceutical Industries Ltd.: News/Key Developments, 2022-2024
Table 94 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 95 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 96 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 97 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024
Table 98 : WuXi AppTec: Company Snapshot
Table 99 : WuXi AppTec: Financial Performance, FY 2022 and 2023
Table 100 : WuXi AppTec: Product Portfolio
Table 101 : WuXi AppTec: News/Key Developments, 2022-2024

List of Figures

Summary Figure : Global Market Shares of APIs, by Production Method, 2023
Figure 1 : End-to-End Pharmaceutical Supply Chain
Figure 2 : API Market Supply Chain
Figure 3 : Chemical Synthetic Process
Figure 4 : Schematic Representation of Biological Production Process for APIs
Figure 5 : Market Dynamics of Active Pharmaceutical Ingredients (APIs)
Figure 6 : U.S. FDA ANDA Approvals, by Fiscal Year, 2020-2023
Figure 7 : Share of U.S. FDA ANDA Approvals, by Generic Drug Type, 2020-2023
Figure 8 : Share of Drug Molecules Approved by the FDA, by Molecule Type, 2016 to 2023
Figure 9 : Novel Drugs Approved by the FDA, by Drug Type, 2018-2023
Figure 10 : Global Market Shares of APIs, by Manufacturer Type, 2023
Figure 11 : Global Market Shares of Captive and Contract Manufacturer APIs, by Region, 2023
Figure 12 : Global Market Shares of Merchant APIs, by Region, 2023
Figure 13 : Global Market Shares of APIs, by Production Method, 2023
Figure 14 : Global Market Shares of Biotech APIs, by Production Method, 2023
Figure 15 : Global Market Shares of APIs, by Molecule Type, 2023
Figure 16 : Global Market Shares of Small-Molecule APIs, by Type, 2023
Figure 17 : Global Market Shares of Small-Molecule APIs, by Manufacturer Type, 2023
Figure 18 : Global Market Shares of Large-Molecule APIs, by Type, 2023
Figure 19 : Global Market Shares of Large-Molecule APIs, by Manufacturer Type, 2023
Figure 20 : Global Market Shares of APIs, by Region, 2023
Figure 21 : Location of API Manufacturers Serving the U.S. Market, as of August 2023
Figure 22 : Location of Finished Dosage Forms (FDF) Manufacturers Serving U.S. Market, as of August 2023
Figure 23 : Sources of APIs Used in Medications Consumed in the U.S., Market Share by Dollar Value, 2021
Figure 24 : Biopharmaceutical Manufacturing Facilities in the U.S., 2018-2023
Figure 25 : North American Market for APIs, by Manufacturer Type, 2023
Figure 26 : North American Market for APIs, by Production Method, 2023
Figure 27 : North American Market for APIs, by Molecule Type, 2023
Figure 28 : North American Market for APIs, by Country, 2023
Figure 29 : European Market Shares of APIs, by Manufacturer Type, 2023
Figure 30 : European Market Shares of APIs, by Production Method, 2023
Figure 31 : European Market Shares of APIs, by Molecule Type, 2023
Figure 32 : European Market Shares of APIs, by Country, 2023
Figure 33 : Share of Manufacturing Sites of APIs for U.S. Market, by Country/Region, August 2019
Figure 34 : India's Drug and Pharmaceuticals Exports, 2016/2017 to 2023/2024
Figure 35 : Asia-Pacific Market Shares of APIs, by Manufacturer Type, 2023
Figure 36 : Asia-Pacific Market Shares of APIs, by Production Method, 2023
Figure 37 : Asia-Pacific Market Shares of APIs, by Molecule Type, 2023
Figure 38 : Asia-Pacific Market Shares of APIs, by Country, 2023
Figure 39 : RoW Market Shares of APIs, by Manufacturer Type, 2023
Figure 40 : RoW Market Shares of APIs, by Production Method, 2023
Figure 41 : RoW Market Shares of APIs, by Molecule Type, 2023
Figure 42 : RoW Market Shares of APIs, by Country, 2023
Figure 43 : Aurobindo Pharma: Revenue Share, by Business Unit, FY 2024
Figure 44 : Aurobindo Pharma: Revenue Share: Revenue Share, by Country/Region, FY 2024
Figure 45 : Divi's Laboratories Ltd.: Revenue Share, by Country/Region, FY 2024
Figure 46 : EUROAPI: Revenue Share, by Business Unit, FY 2023
Figure 47 : Evonik Industries AG: Revenue Share, by Business Unit, FY 2023
Figure 48 : Evonik Industries AG: Revenue Share, by Region, FY 2023
Figure 49 : Lonza: Revenue Share, by Business Unit, FY 2023
Figure 50 : Lonza: Revenue Share, by Region, FY 2023
Figure 51 : Pfizer Inc.: Revenue Share, by Business Unit, 2023
Figure 52 : Pfizer Inc.: Revenue Share, by Country/Region, 2023
Figure 53 : Siegfried Holding AG: Market Share, by Business Unit, 2023
Figure 54 : Teva Pharmaceutical Industries Ltd.: Market Share, by Business Unit, 2023
Figure 55 : Thermo Fisher Scientific Inc.: Market Share, by Business Unit, 2023
Figure 56 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023
Figure 57 : WuXi AppTec: Revenue Share, by Business Unit, FY 2023
Figure 58 : WuXi AppTec: Revenue Share, by Country/Region, FY 2023